The trends shaping the growth of the biologics outsourcing industry demand attention.

The Logistics of Outsourcing Biologics

It is important to understand regulatory requirements and study challenges at the clinical stage.

Robust Bioanalytical Studies Can Aid in Regulatory Submissions

Automation of pharmaceutical packaging saves costs and time, say contract packagers.

Automating Packaging of Bio/Pharmaceuticals

Topic

Articles

Contract testing services demonstrate a major increase in the speed and efficiency of testing using new testing methods and technologies.

Contract Testing Services Solidify Their Place in the Manufacturing Value Chain

Anil Kane, executive director, Global Head of Technical & Scientific Affairs at Thermo Fisher Scientific, discusses the growing role of CDMOs in the biopharma industry

Discussing the Growing Role of CDMOs with Anil Kane (DCAT 2023)

Stephen Houldsworth, VP and Head of Platform Management & Marketing at CordenPharma, dives into ongoing trends in the outsourcing space.

Illuminating the State of Outsourcing with Stephen Houldsworth (DCAT 2023)

Susan Haigney is managing editor of BioPharm International, susan.haigney@ubm.com.

In addition to a new interim president, the company is opening new microbial capacity at its San Antonio facility and has plans to construct a commercial-scale facility in Manhattan, Kan.

Scorpius BioManufacturing Announces New Microbial Capacity and New Interim President

Actylis new 30,000-ft² API manufacturing facility is located in Eugene, Ore.

Actylis Opens 30,000-square-foot API Manufacturing Facility

Editor of Pharmaceutical Technology Europe

Podcasts

In this episode, Rhonda Henry and Adam Mendizabal from Emmes discuss the role CROs play in cell and gene therapies undergoing clinical trials at all stages.

Drug Solutions Podcast: How CROs Adapt Themselves in the Ever-Changing Landscape of Cell and Gene Therapies

The bio/pharma outsourcing industry continues to be integral in the development and manufacture of medicines. 

Outsourcing Still Vital

Quotient Sciences’ facility expansion is designed to increase support for fully integrated drug development programs.

Quotient Sciences Expands Formulation Development Capabilities at Nottingham Facility

is an executive director at WuXi Biologics.

Wesley Wang is vice-president at WuXi Biologics.

Weichang Zhou is president at WuXi Biologics.

In this paper, the authors lay out some commonly accepted HCP analytical methods, the challenges of HCP assay, and provide recommendations on what can easily be accomplished in-house and when it may be better to outsource.